Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study
- PMID: 33351817
- PMCID: PMC7755188
- DOI: 10.1371/journal.pone.0238552
Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study
Abstract
Purpose: To describe the trajectory of respiratory failure in COVID-19 and explore factors associated with risk of invasive mechanical ventilation (IMV).
Materials and methods: A retrospective, observational cohort study of 112 inpatient adults diagnosed with COVID-19 between March 12 and April 16, 2020. Data were manually extracted from electronic medical records. Multivariable and Univariable regression were used to evaluate association between baseline characteristics, initial serum markers and the outcome of IMV.
Results: Our cohort had median age of 61 (IQR 45-74) and was 66% male. In-hospital mortality was 6% (7/112). ICU mortality was 12.8% (6/47), and 18% (5/28) for those requiring IMV. Obesity (OR 5.82, CI 1.74-19.48), former (OR 8.06, CI 1.51-43.06) and current smoking status (OR 10.33, CI 1.43-74.67) were associated with IMV after adjusting for age, sex, and high prevalence comorbidities by multivariable analysis. Initial absolute lymphocyte count (OR 0.33, CI 0.11-0.96), procalcitonin (OR 1.27, CI 1.02-1.57), IL-6 (OR 1.17, CI 1.03-1.33), ferritin (OR 1.05, CI 1.005-1.11), LDH (OR 1.57, 95% CI 1.13-2.17) and CRP (OR 1.13, CI 1.06-1.21), were associated with IMV by univariate analysis.
Conclusions: Obesity, smoking history, and elevated inflammatory markers were associated with increased need for IMV in patients with COVID-19.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: SYC consults for PureTech on their deupirfenidone in COVID study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures


Update of
-
Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19: a Retrospective, Observational Cohort Study.medRxiv [Preprint]. 2020 Aug 14:2020.08.12.20173849. doi: 10.1101/2020.08.12.20173849. medRxiv. 2020. Update in: PLoS One. 2020 Dec 22;15(12):e0238552. doi: 10.1371/journal.pone.0238552. PMID: 32817959 Free PMC article. Updated. Preprint.
References
-
- WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [cited 2020 Jun 16]. Available from: https://covid19.who.int/
-
- Solaimanzadeh I. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19). Cureus J Med Sci [Internet]. 2020. March 20 [cited 2020 Jun 6];12(3). Available from: https://www.cureus.com/articles/29004-acetazolamide-nifedipine-and-phosp... - PMC - PubMed
-
- Luks AM, Swenson ER. COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications. Ann Am Thorac Soc [Internet]. 2020. April 24 [cited 2020 Jun 6]; Available from: https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202004-327FR - DOI - PubMed
-
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020. March 27 [cited 2020 Apr 7]; Available from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763845 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous